Schedule 13G ownership disclosure
Biohaven Pharmactl Hldg Co
Security class unavailable · CUSIP: G11196105
Event date: 2022-05-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,446,156
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-22-000152
- Form type
- SC 13G
- Filer
- Biohaven Pharmaceutical Holding Co Ltd.
- CIK
- CIK 1689813
- Filed
- Jun 10, 2022
- Reporting period
- May 31, 2022
- Description
- Schedule 13G beneficial ownership